Recent research
We have collated a selection of the latest research articles to help you keep up to date with developments in the field of prostate cancer. This page directs you to the abstracts of articles that have been published in the medical journals over the last few weeks. Check back each month for an updated list.
The following articles have been selected for their currency, relevance to UK clinical practice and general interest. The full text may be obtained from your Trust’s library service or via ATHENS registration.
Archive - Research articles published April 2008
View articles on:
- Genetics
- Ethnicity
- Diet
- Prevention
- Patient choice
- Diagnosis
- BPH
- Treatment
- Side effects
- Quality of life
- Advanced disease
- Mortality
- Cancer services
Genetics
Polymorphisms in angiogenesis-related genes and prostate cancer
Jacobs EJ, Hsing AW, Bain EB et al
Cancer Epidemiol. Biomarkers Prev. 2008; 17(4): 972-7
Ethnicity
Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis
Evans S, Metcalfe C, Ibrahim F et al
Int. J Cancer; advanced online publication (May 2008)
Diet
Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg)
Nimptsch K, Rohrmann S, and Linseisen J
Am. J. Clinical Nutrition 2008; 87(4): 985-92
Prevention
Five-alpha-reductase Inhibitors for prostate cancer prevention
Wilt T, Macdonald R, Hagerty K et al
Cochrane Database Syst Rev. 2008 16;(2):CD007091.
Patient choice
Health information styles among participants in a prostate cancer screening informed decision-making intervention
Williams-Piehota PA , McCormack LA, Treiman K et al
Health Education. Research; advanced online publication April 2008
Diagnosis
Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter
Ahyai SA, Graefen M, Steuber T et al
Eur Urol. 2008;53(4):750-7
Negative influence of changing biopsy practice patterns on the predictive value of prostate-specific antigen for cancer detection on prostate biopsy.
Schwartz MJ, Hwang DH, Hung AJ et al
Cancer 2008; 112(8):1718-25
Current Applications for Prostate-Specific Antigen Doubling Time
Ramírez ML, Nelson EC, Devere White RW et al
Eur Urol.; advanced online publication (April 2008)
Digital Rectal Examination and the Diagnosis of Prostate Cancer-a Study Based on 8 Years and Three Screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam
Gosselaar C, Roobol MJ, van den Bergh RC et al
Eur Urol.; advanced online publication (April 2008)
BPH
Testosterone levels in benign prostatic hypertrophy and prostate cancer
Mearini L, Costantini E, Zucchi A et al
Urol Int. 2008; 80(2):134-40
Treatment
Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies
Veldeman L, Madani I, Hulstaert F et al
Lancet Oncol. 2008; Apr;9(4):367-75
Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer
Mitchell DM, Swindell R, Elliott T et al
Radiother Oncol. 2008; advanced online publication (April 2008)
Watchful waiting and active surveillance: the current position.
Adolfsson J.
BJU Int; advanced online publication (April 2008)
Visit the publisher’s website www.blackwell-synergy.com
The addition of robotic surgery to an established laparoscopic radical prostatectomy program: effect on positive surgical margins
Trabulsi EJ, Linden RA, Gomella LG et al
Canadian Journal of Urology 2008;15(2):3994-9
PSA in the New Millennium: A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes — Results from the SEARCH Database
Freedland SJ, Hotaling JM, Fitzsimons NJ et al
Eur Urol. 2008; 53(4):758-64;
Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer
Horwitz EM, Bae K, Hanks GE et al
J Clin Oncol.; advanced online publication (April 2008)
Testosterone Surge: Rationale for Gonadotropin-Releasing Hormone blockers?
van Poppel H, Nilsson S.
Urology; advanced online publication (April 2008)
Use of androgen deprivation therapy for metastatic prostate cancer in older men
Keating NL, O'Malley AJ, McNaughton-Collins M et al
BJU Int. 2008;101(9):1077-83
Side effects
Phosphodiesterase type 5 inhibitors in the management of erectile dysfunction secondary to treatments for prostate cancer: findings from a Cochrane systematic review.
Candy B, Jones L, Williams R et al
BJU Int; advanced online publication (April 2008)
Visit the publisher’s website www.blackwell-synergy.com
Quality of life
The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer
Karakiewicz PI, Bhojani N, Neugut A et al
J Sex Med. 2008; 5(4):919-27
Oncosexuality
White I.
Cancer Nursing Practice 2008: 7(3); 14 -15
Visit the publisher’s website www.rcnpublishing.co.uk
Advanced disease
Experiences of symptoms in men with hormone refractory prostate cancer and skeletal metastases
Lindqvist O, Rasmussen BH, Widmark A.
Eur J Oncol Nurs. ; advanced online publication (April 2008)
Mortality
Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study
Collin SM, Martin RM, Metcalfe C et al
Lancet Oncol. 2008; 9(5):445-52
Cancer services
The success of a nurse-led, one-stop suspected prostate cancer clinic
James N and McPhail G
Cancer Nursing Practice 2008; 7(3):28-32
Visit the publisher’s website www.rcnpublishing.co.uk
Mapping the English cancer clinical nurse specialist workforce
Trevatt P, Petit J and Leary A
Cancer Nursing Practice 2008; 7(3): 33-38
Visit the publisher’s website www.rcnpublishing.co.uk